tirzepatide patient assistance program eli lilly What is Cares Lilly Shows Tirzepatide Superiority in

All data are preliminary and may change as additional data are obtained

Does the body eventually fully adapt, or does continuous GLP-1 exposure permanently reset your baseline

Tirzepatide has given excellent results for patients in clinical trials like SURMOUNT-1

One such option is Mounjaro (tirzepatide), a once-weekly injectable medication that was originally approved for type 2 diabetes and is now FDA-approved for weight management in adults with obesity or overweight and at least one weight-related health condition

Frequently Asked Questions Tirzepatide is the only treatment that activates both GIP and GLP-1 receptors

NICE guidance recommends tirzepatide for eligible adults with obesity and at least one weight-related comorbidity